Linezolid Optic Neuropathy
Downloads
Published
DOI:
https://doi.org/10.56692/upjo.2024120106Keywords:
Linezolid, Optic neuropathy, Scotoma.Dimensions Badge
Issue
Section
License
Copyright (c) 2024 Radhika Gupta, Richa Chauhan, Reena Sharma, Narendra Gupta, Mafat Lal, Ravi Ranjan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
© UPJO, 2023 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.
Various systemic antimicrobials have been known to cause ocular adverse effects. Linezolid has been shown to be effective in treating multidrug-resistant tuberculosis. Though, long-term treatment is discontinued by the related side effects, such as ocular and peripheral neuropathy. In a developing country like India, where there is increasing burden of multidrug-resistant tuberculosis, ophthalmologists and physicians should be aware of linezolid induced optic neuropathy so that monitoring of visual functions in patients on long-term linezolid treatment can be done to avoid serious neurological consequences.Abstract
How to Cite
Downloads
